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ABSTRACT
Cytoplasmic localization, stability, and translation of mRNAs are controlled by their dynamic association of numerous
mRNA-binding (mRNP) proteins, including cold shock domain (CSD)-containing proteins, heterogeneous nuclear ribonu-
cleoproteins (hnRNPs), and serine/arginine-rich (SR) proteins. Here, we demonstrate that the most abundant human
mRNPprotein, the CSD-containing Y-box-binding protein 1 (YBX1), the closely related YBX3protein, and othermRNPpro-
teins, such as SRSF1, SRSF2, SRSF3, hnRNP A1, and H, specifically and efficiently interact with overlapping sets of mito-
chondrial tRNAs (mt tRNAs). In vitro reconstitution and in vivo binding experiments show that YBX1 recognizes the
D- and/or T-stem–loop regions of mt tRNAs through relying on the RNA-binding capacity of its CSD. Cell fractionation
and in vivo RNA–protein cross-linking experiments demonstrate that YBX1 and YBX3 interact with mt tRNAs in the cytosol
outside of mitochondria. Cell fractionation and fluorescence in situ hybridization experiments provide evidence that mito-
chondrial autophagy promotes the release of mt tRNAs from the mitochondria into the cytoplasm. Association of mRNP
proteins with mt tRNAs is highly dynamic; it is rapidly increased upon transcription inhibition and decreased during apo-
ptosis. Although the cytoplasmic function of mt tRNAs remains elusive, their dynamic interactions with key mRNA-binding
proteins may influence cytoplasmic mRNA stability and/or translation.
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INTRODUCTION
Human Y-box-binding proteins YBX1, YBX3, and the germ
cell–specific YBX2 belong to the superfamily of cold shock
domain (CSD) proteins (Wolffe et al. 1992; Graumann and
Marahiel 1998). CSD is an evolutionarily highly conserved,
single-stranded nucleic acid–binding domain encompass-
ing two RNA-recognition motifs, RNP-1 and RNP-2, which
are common to many RNA-binding proteins (Kloks et al.
2002). Through interacting with nucleic acids, the Y-box-
binding proteins function in a broad variety of cellular pro-
cesses, including nuclear DNA replication, DNA repair,
transcription, and mRNA processing (Eliseeva et al. 2011;
Lyabin et al. 2014). Together with numerous hnRNP pro-
teins and serine/arginine-rich (SR) proteins, YBX1 and
YBX3 bind to the newly synthesized precursor mRNAs
(pre-mRNAs). They regulate pre-mRNA splicing and poly-
adenylation, promote mRNA export to the cytoplasm, and
control cytoplasmic mRNA translation, stability, and local-
ization (Eliseeva et al. 2011; Lyabin et al. 2014; Singh et al.
2015). Besides polyadenylate-binding protein 1 (PABP1),
YBX1 is the major interactor of cytoplasmic mRNAs
(Minich et al. 1993; Evdokimova et al. 1995; Singh et al.
2015). Dynamic association of YBX1 with mRNAs controls
the cytoplasmic stability and translation of a large set of
mRNAs (Evdokimova et al. 1998, 2006; Lyabin et al.
2014). The regulatory mechanisms controlling association
of YBX1 and other mRNP proteins with cytoplasmic
mRNAs is poorly understood. Recently, cytoplasmic (cyt)
tRNA fragments (tRFs) produced by stress-activated angio-
genin have been found to possess high affinity to YBX1
and have been demonstrated to destabilize YBX1-associ-
ated mRNAs by competitively displacing them from
YBX1 (Goodarzi et al. 2015).
Mitochondria are double membrane–bound cytoplas-
mic organelles that function primarily in cellular energy
production though ATP synthesis by oxidative phosphory-
lation. The 16.6-kb human circular mitochondrial DNA en-
codes 13 mitochondrial proteins involved in oxidative
phosphorylation, two mitochondrial ribosomal RNAs (12S
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and 16S rRNAs), and the complete set of 22 mt tRNAs suf-
ficient for mitochondrial protein synthesis (Hällberg and
Larsson 2014). The limited protein-coding capacity of mi-
tochondrial DNA is compensated by selective importation
of about 1500 nuclear-encoded proteins from the cyto-
plasm (Neupert and Herrmann 2007). All human mt
tRNAs are synthesized within and processed from long
polycistronic transcripts by RNase P and ELAC2 within
the mitochondrion (Dubrovsky et al. 2004; Holzmann
et al. 2008; Brzezniak et al. 2011; Rossmanith 2011). To
produce functional mt tRNAs, several internal nucleotides
are covalently modified and the tRNA nucleotidyltransfer-
ase adds the 3′-terminal CCA trinucleotide (Nagaike et al.
2001; Salinas-Giegé et al. 2015). The mature mt tRNAs
possess noncanonical cloverleaf structures distinct from
cyt tRNAs (Watanabe 2010; Suzuki et al. 2011).
The cellular function ofmt tRNAs has longbeen confined
to mitochondrial protein synthesis. Recent studies, howev-
er, raised the fascinating concept that mt tRNAs may have
additional, unexpected regulatory functions outside of mi-
tochondria. The Yang laboratory reported that human mt
tRNAs function as negative regulators of apoptosis through
binding to the mitochondrial apoptosome activator cyto-
chrome c (Cyt c) (Mei et al. 2010). Docking ofmt tRNAs pre-
vents Cyt c binding to the cytosolic protease activating
factor 1 (Apaf-1), which is essential for Apaf-1-mediated
caspase activation and apoptosis (van Raam and Salvesen
2010). Cyt c and mt tRNAs are likely released from the mi-
tochondria in response to intrinsic apoptotic signals that
can promote mitochondrial membrane permeabilization
and lesion formation (Zhan et al. 2013). Other studies sug-
gested that humanmt tRNAs, or at least some of them, are
present in the cytosol even under normal physiological
conditions. Human mt tRNAMet has been found to specifi-
cally interact with argonaute-2 (Ago2), a key component of
the cytoplasmic RNA-induced silencing complex (Mania-
taki and Mourelatos 2005). More recently, our laboratory
demonstrated that the human polypyrimidine tract-bind-
ing mRNP protein PTB and its tissue-specific paralogs
PTB2 and PTB3 bind with great specificity to mt tRNAThr
in the cytoplasm (Marnef et al. 2016). PTB interaction with
mt tRNAThr is augmented during apoptosis, pointing to a
potential participation of the PTB/mt tRNAThr complex in
apoptosis.
In this study, we demonstrate that a fraction of human
HeLa mt tRNAs accumulate in the cytoplasm where they
specifically interact with abundant mRNP proteins, includ-
ing the YBX1 and YBX3 CSD proteins, the SRSF1, SRSF2,
and SRSF3 SR proteins, and the hnRNP A1 and H proteins.
Cytoplasmic association of mt tRNAs with mRNP proteins
is highly dynamic, it is rapidly augmented in transcrip-
tionally arrested cells, and is reduced in apoptotic cells.
Although the function of cytoplasmic association of mt
tRNAs and mRNP proteins remains unknown, our observa-
tions reinforce the currently emerging idea that besides
supporting mitochondrial protein synthesis, mt tRNAs
also possess other functions in the cytoplasm.
RESULTS
Human YBX1 and YBX3 interact with mt tRNAs
The human CSD proteins YBX1 and YBX3 have been iden-
tified as potential interactors of the 7SK transcriptional
regulatory snRNA (Hogg and Collins 2007; McNamara
et al. 2016; B Jady, A Ketele, T Kiss, unpubl.). To confirm
in vivo association of YBX1 and YBX3 with 7SK, both pro-
teins were immunoprecipitated with specific antibodies
from a HeLa total cell extract depleted of large RNPs.
RNAs copurified with YBX1 and YBX3 were 3′ end-labeled
with [5′-32P]pCp and T4 RNA ligase and size-fractionated
on a 6% sequencing gel (Fig. 1A, lanes 2,4). Immunopre-
cipitation (IP) of both YBX1 and YBX3 pulled down the
7SK snRNA and, more relevant to this study, also recov-
ered a group of 60- to 80-nt-long small RNAs. The same
set of RNAs were recovered upon IP of transiently ex-
pressed HA- and Flag-tagged YBX1 and YBX3 with anti-
HA and anti-Flag antibodies (lanes 6,7,9,10). Moreover, a
similar RNA profile was obtained upon analysis of RNAs
coimmunopurified with transiently expressed TAP-tagged
YBX3 (Supplemental Fig. S1). IP of endogenous and tran-
siently expressed epitope-tagged YBX1 and YBX3 pro-
teins was confirmed by western blot analysis (Fig. 1B).
To determine the identity of small RNAs copurified with
YBX1, several 3′ end-labeled RNAs were isolated from the
gel and subjected to direct chemical sequencing. Gel elec-
trophoretic fractionation of the base-specific degrada-
tion products provided clear sequencing patterns for six
RNAs that, to our surprise, corresponded to mt tRNAs
Phe, Lys, Ser(AGY), Val, Leu(UUR), and Gly (Supplemental
Fig. S2A). In the sequencing ladders, the uridine reactions
contained a few gaps that likely indicate hydrazine-resis-
tant pseudouridines, suggesting that mt tRNAs associated
with YBX1 are post-transcriptionally modified. Next, 3′ end
race experiments followed by sequence analyses demon-
strated that most YBX1-associated mt tRNAs Phe, Lys,
and Gln carry the nontemplated 3′-terminal CCA ribonu-
cleotides ofmature tRNAs, although∼30%of the obtained
sequences lacked the last A, CA, CCA, or NCCA residues
(Supplemental Fig. S2B, and data not shown). This indi-
cates that the YBX1-associatedmt tRNAs are correctly pro-
cessed, but they undergo slight 3′ end trimming in the cell
or in the extract used for IP.
Northern blot analysis was used to compare the interac-
tions of mt tRNAs with YBX1 and YBX3 (Fig. 1C). Apart
from mt tRNAs Arg, Cys, Leu(CUN), and Thr, all mt
tRNAs copurifiedwith YBX1 and YBX3, albeit with different
efficiencies. In contrast, we failed to detect any of the test-
ed cyt tRNAs Asp, Leu, Glu, Lys, Phe, and the Y5 small cy-
toplasmic RNA among YBX1- and YBX3-associated RNAs
Human mRNP proteins bind to mitochondrial tRNAs
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(Supplemental Fig. S3). IP of endogenous YBX1, YBX3,
and transiently expressed FL-YBX1 from human MCF7,
MRC5V1, U2OS, VA13, and primary fibroblast cell extracts
recovered mt tRNAs Lys and Phe (Fig. 2A–C). Likewise, IP
of mouse YBX1 from a L929 cell extract recovered three
out of the four tested mt tRNAs (Fig. 2D). We concluded
that association of human mt tRNAs with YBX1 and YBX3
is conserved at least in human and mouse cells.
YBX1 and YBX3 directly interact with mt tRNAs
Todemonstrate thatYBX1andYBX3 interactwithmt tRNAs
in living cells, weperformed in vivoRNA–protein cross-link-
ingexperiments (Fig. 3A). Because the
available YBX1 and YBX3 antibodies
performed poorly under stringent IP
conditions required to destroy nonco-
valent RNA–protein interactions, tran-
siently expressed Flag-tagged YBX1
and YBX3 were immunoprecipitat-
ed with an anti-Flag antibody. Before
extract preparation, the transfected
cells were treated with formaldehyde
to fix in vivo RNA–protein interactions
(Niranjanakumari et al. 2002). With-
out formaldehyde cross-linking, IP of
FL-YBX1 and FL-YBX3 under harsh
conditions failed to recover significant
amounts ofmt tRNAs Lys, Phe, andVal
(lanes 5,11). In contrast, in vivo cross-
linking significantly increasedcopurifi-
cation of the tested mt tRNAs with
both YBX1 andYBX3 (lanes 6,12), con-
firming that YBX1 and YBX3 directly
interact with mt tRNAs in living cells.
As expected, neither YBX1 nor YBX3
showed detectable association with
cyt tRNAGln(UUG) even after formalde-
hyde cross-linking.
To confirm direct interaction of
YBX1 and YBX3 with mt tRNAs, we
performed gel electrophoretic mobil-
ity shift assays (Fig. 3B). In vitro synthe-
sized internally labeled mt tRNAs Asn,
Lys, Ala, Phe, Gly, and Leu(UUR) were
incubated with increasing amounts
of recombinant YBX1 and YBX3 pro-
teins, and the resulting complexes
were analyzed by native gel electro-
phoresis. Each mt tRNA showed YBX1
and YBX3 concentration-dependent
mobility retardation that was abol-
ished by inclusion of the correspond-
ing cold competitor mt tRNA. The
supershifts frequently observed in
YBX1 reactions likely reflect in vitro YBX1 dimerization
(Evdokimova et al. 1995). In contrast to mt tRNAs, the cyt
tRNAGln(TTG) failed to interact with YBX1 and YBX3. In vitro
association ofmt tRNAPhewith YBX1 andYBX3wasdisrupt-
ed by inclusion of excessive amounts of other cold mt
tRNAs, such as Phe, Lys, and Gly, but remained unaffected
in the presence of cold cyt tRNAGln(TTG) (Fig. 3C). These re-
sults demonstrate that YBX1 andYBX3 formdirect and spe-
cific interactions with mt tRNAs.
Next, HeLa cell extracts were fractionated by sucrose
gradient velocity sedimentation to learn about the natures
of YBX1- and YBX3-mt tRNA complexes (Fig. 3D). The gra-
dients were divided into 14 fractions and upon IP of YBX1
A
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FIGURE 1. Human YBX1 and YBX3 interact with mt tRNAs. (A) Small RNAs associated with
YBX1 and YBX3. HeLa cellular RNAs coimmunopurified with endogenous or transiently ex-
pressed HA- and Flag-tagged YBX1 and YBX3 were 3′ end-labeled and analyzed on 6% se-
quencing gels. Control IPs with nonimmune sera (cont IP) or from nontransfected cell extracts
(NT) are shown. The 7SK snRNA and YBX1-associated mt tRNAs identified by direct chemical
sequencing are indicated. (Lanes M) Size markers in nucleotides. (B) Western blot analyses.
IP of HeLa endogenous and transiently expressed epitope-tagged YBX1 and YBX3 was con-
firmed by YBX1- and YBX3-specific antibodies. (Ext) HeLa cell extracts. Positions of marker pro-
teins are indicated. (C ) Copurification of HeLamt tRNAswith YBX1 and YBX3wasmeasured by
northern blot analyses with sequence-specific oligonucleotide probes. IP of YBX1 and YBX3
was confirmed by western blotting. (Ext) HeLa cell extract (50× dilution). (LaneM ) Sizemarkers.
Jády et al.
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and YBX3 from each fraction (bottom panels), copurifica-
tion of mt tRNAs Lys, Phe, Leu(UUR), and Val were moni-
tored by northern blot analyses (middle panels). YBX1
and YBX3 were found mostly in the upper parts of the gra-
dients (5S–40S), but consistent with their proposed role in
mRNA translation regulation, they were also detected in
the lower part of the gradient containing rapidly sediment-
ing large complexes. Themt tRNAs Lys, Phe, and Leu(UUR)
coprecipitated with YBX1 and YBX3 predominantly from
the top two fractions, suggesting that they form simple het-
erodimeric complexes with YBX1 and YBX3. Supporting
this notion, mass spectrometry failed to identify additional
proteins coprecipitated with YBX1- and YBX3-mt tRNA
complexes. Interestingly, only a fraction of mt tRNAVal
was detected in low mobility YBX1 and YBX3 complexes,
more than half of mt tRNAVal associated with YBX1 and
YBX3 was incorporated into large 35S–50S complexes of
unknown nature. Recently, mt tRNAVal has been identified
as an integral component of the39S large subunit of human
mitochondrial ribosomes (Brown et al. 2014). However,
YBX1 and YBX3 are absent frommitochondria (see below),
excluding their association with mitochondrial ribosomes.
RNA and protein elements supporting YBX1
interactions with mt tRNAs
To determine the elements of mt tRNAs directing YBX1
binding, in vitro synthesized internally labeled wild-type
and mutant mt tRNAs Gly and Leu(UUR) were transfected
into HeLa cells (Fig. 4A). After 24 h of incubation, endoge-
nous YBX1 was immunoprecipitated and copurification of
the labeled test RNAs was monitored by gel electrophore-
sis followed by autoradiography. IP of YBX1 was confirmed
bywestern blot analysis. All transfected RNAs proved to be
stable in HeLa cells (lanes Ext). As expected, both wild-
type tRNAs interacted with YBX1 (lanes 3,21). Removal
of the D stem–loop (dDS) had no effect on YBX1 binding
to the truncated mt tRNAGly (lane 6), but fully abolished
YBX1 interaction with the shortened mt tRNALeu(UUR)
(lane 24). Elimination of the T stem–loop (dTS) interrupted
YBX1 binding to mt tRNAGly (lane 12), but failed to influ-
ence YBX1 interaction with mt tRNALeu(UUR) (lane 30). In
line with these observations, alteration of the T and D
loop sequences (mTL and mDL) of mt tRNAGly and mt
tRNALeu(UUR), respectively, abolished association of the
mutant mt tRNAs with YBX1 (lanes 15,33). Deletion of
the anticodon (A) stem–loop (dAS) inhibited interaction
of both truncated mt tRNAs with YBX1 (lanes 9,27).
However, computer-mediated structure predictions indi-
cated that in contrast to removal of the T and D stem–
loops, deletion of the A stem–loops interferes with proper
folding of the truncated mt tRNAs (Supplemental Fig. S4).
Alteration of the anticodon loop sequences (mAL) had no
influence on the YBX1 binding capacities of the mutant mt
tRNAGly and mt tRNALeu(UUR) (lanes 18,36), suggesting that
besides promoting correct RNA folding, the A stem–loop
A B C
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FIGURE 2. Conservation of YBX1 and YBX3 interaction withmt tRNAs in human andmouse cells. (A) YBX1 and YBX3 interaction withmt tRNAs in
human cell lines. YBX1 and YBX3 were immunoprecipitated from extracts (Ext) of HeLa, MCF7, MRC5V1, U2OS, and VA13 cells. IP of YBX1 and
YBX3 and copurification of mt tRNALys and mt tRNAPhe were monitored by western and northern blot analyses, respectively. (B) Transiently ex-
pressed Flag-tagged YBX1 interacts with endogenous mt tRNALys and mt tRNAPhe in human HeLa, MCF7, MRC5V1, U2OS, and VA13 cells.
FL-YBX1 was immunoprecipitated with an anti-Flag antibody from extracts (Ext) of nontransfected (NT) and transfected (pFL-YBX1) cells. IP of
FL-YBX1 and co-IP of mt tRNALys and mt tRNAPhe were monitored by western and northern blotting. (C ) YBX1 interacts with mt tRNALys and mt
tRNAPhe in human primary fibroblast cells. Please note that fibroblast cells do not express YBX3. (D) Mouse YBX1 binds to mt tRNAs. Mouse
YBX1 (mYBX1)was immunoprecipitated fromanL929cell extractwith a specificantibody, andcoprecipitationof four selectedmt tRNAswas tested.
Human mRNP proteins bind to mitochondrial tRNAs
www.rnajournal.org 1709
 Cold Spring Harbor Laboratory Press on January 30, 2019 - Published by rnajournal.cshlp.orgDownloaded from 
has no or little impact on YBX1 binding. Thus, we conclud-
ed that YBX1 binding is directed primarily by the D stem–
loop region of mt tRNALeu(UUR) and the T stem–loop of mt
tRNAGly. Nucleotide alterations that maintained the dou-
ble-stranded nature of the D stem of tRNA Leu(UUR)
(mDS) or the T stem of tRNA Gly (mTS) had no effect on
the YBX1-binding capacities of the mutant RNAs (lanes
39,42). Swapping the T and D stem–loops of tRNAs Gly
and Leu(UUR) for the Leu(UUR) D and the Gly T stem–
loops, respectively, maintained in vivo YBX1 binding, fur-
ther demonstrating that these elements contain the key
structural information for YBX1 recognition (lanes 45,48).
It is noteworthy that PTB binding to mt tRNAThr is also co-
ordinated by the D and T stem–loops of the tRNA (Marnef
et al. 2016).
To test the importance of the CSD of YBX1 in mt tRNA
binding, we performed gel-shift assays (Fig. 4B). In vitro
synthesized labeled mt tRNAPhe was incubated with a mu-
tant recombinant YBX1 protein (YBX1CSDm) carrying the
W65G, F66A, F74A, F85A, andH87GCSDpointmutations
that are predicted to interfere with RNA ligand binding
(Max et al. 2007; Sachs et al. 2012). Compared to wild-
type YBX1 (lane 7), the mutant YBX1CSDm showed weak
in vitro association with mt tRNAPhe (lanes 2–5). We also as-
sayed the in vivo mt tRNA binding capacity of the mutant
YBX1CSDm protein expressed in HeLa cells (Fig. 4C).
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FIGURE 3. YBX1 and YBX3 directly interact with mt tRNAs. (A) In vivo RNA–protein cross-linking. Extracts (Ext) were prepared from formalde-
hyde-treated (x-link) or nontreated (cont) HeLa cells expressing FL-YBX1 or FL-YBX3. After IP with an anti-Flag antibody under stringent condi-
tions, recovery of FL-YBX1 and FL-YBX3 was monitored by western blotting, and co-IP of mt tRNAs Lys, Phe, and Val, as well as cyt tRNAGln, was
measured by northern blotting. (NT) Nontransfected cells. (B) Gel shift analysis. In vitro synthesized 32P-labeled mt and cyt tRNAs (1 fmol) were
incubated without or with increasing amounts of recombinant YBX1 and YBX3 proteins (0.1, 0.2, 0.8, and 4 pmol) in the absence or presence of
50 fmol of cold competitor tRNA (tRNA). The resulting complexes were analyzed on 5% native acrylamide gels. (C ) Cross-competition of YBX1
and YBX3 binding tomt tRNAPhe by othermt tRNAs. Labeledmt tRNAPhe (1 fmol) was incubated without or with 4 pmol of recombinant YBX1 and
YBX3 in the absence or presence of cold competitor mt tRNAs (50 fmol) as indicated. (D) Sedimentation analyses of YBX1- and YBX3-mt RNA
complexes. HeLa cell extracts were fractionated by utracentrifugation on 10%–50% sucrose gradients. Each gradient was divided into 14 fractions
before IP of YBX1 and YBX3. Co-IP of selected mt tRNAs was monitored by northern blotting. Distribution of 5.8S rRNA is shown. Positions of
ribosomal particles were determined by UV absorption profiling. Arrows indicate sedimentation directions.
Jády et al.
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In contrast to transiently expressed Xpress-tagged wild-
type YBX1 (lane 6), the mutant Xpress-YBX1CSDm failed
to recover HeLa mt tRNAs Lys and Phe (lane 9) upon IP,
demonstrating that mt tRNA binding is coordinated by
the CSD of YBX1.
YBX1 and YBX3 interact with mt tRNAs in the cytosol
outside of mitochondria
After demonstration that YBX1 and YBX3 specifically and
directly interact with mt tRNAs, we wanted to determine
the subcellular localization of YBX1- and YBX3-mt tRNA
complexes. Because human YBX1 and YBX3 accumulate
in both the cytoplasm and the nucleoplasm, HeLa cells
were first fractionated into crude cytoplasmic and nuclear
fractions. To generate soluble cytoplasmic and nuclear ex-
tracts, mitochondria were depleted from the cytoplasmic
fraction, and the nuclei were sonicated and clarified by
centrifugation. Correctness of the cell fractionation was
confirmed by monitoring the distributions of the Y5 cyto-
plasmic and the U2 nucleoplasmic RNAs (Fig. 5A, lanes
1,5). As expected, YBX1 and YBX3 were detected in
both extracts, but their IP recovered mt tRNAs Lys, Phe,
and Val predominantly from the cytosplasmic extract,
A
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FIGURE 4. Protein and RNA elements directing YBX1 association withmt tRNAGly andmt tRNALeu(UUR). (A) YBX1 binding is directed by the D and
T stem–loop of mt tRNALeu(UUR) and mt tRNAGly, respectively. About 2 fmol of internally labeled wild-type and mutant mt tRNAs carrying internal
truncations (shaded), sequence alterations (boxed) or other mt tRNA elements (italics) were mixed with 2 µg of cold E. coli tRNA and transfected
into HeLa cells. After 24 h of incubation, endogenous YBX1was immunoprecipitated and co-IP of labeled tRNAswas tested. (B) Gel shift analyses.
In vitro transcribed labeledmt tRNAPhe (1 pmol) was incubated without or with 0.2, 0.4, 1.5, and 4 pmol of recombinant mutant (YBX1CSDm) and
4 pmol of wild-type YBX1 in the absence or presence of cold mt tRNAPhe (50 pmol) before analysis on a 5% native gel. (C ) Intact CSD is required
for in vivo association of YBX1 with mt tRNALys and mt tRNAPhe. Transiently expressed Xpress-YBX1 and Xpress-YBX1CSDm were immunopre-
cipitated from transfected or nontransfected (NT) cell extracts and analyzed by western blotting. Co-IP of mt tRNAs Lys and Phewasmonitored by
northern blotting.
Human mRNP proteins bind to mitochondrial tRNAs
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suggesting that YBX1 and YBX3 interact with mt tRNAs in
the cytosol (lanes 3,4). Significance of the observed weak
interaction of YBX1 and YBX3 with mt tRNAs in the nuclear
extract remains unclear (lanes 7,8). Co-IP of YBX1 and
YBX3 from the cytoplasmic fraction could be explained
by their copurification in mRNP particles.
YBX1 and YBX3 lack recognizable mitochondrial target-
ing sequences (Fukasawa et al. 2015; B Jady, A Ketele, T
Kiss, unpubl.), and previous comprehensive analyses failed
to detect these proteins within mitochondria (Mootha
et al. 2003; Pagliarini et al. 2008; Gaston et al. 2009).
Nevertheless, we assayed whether YBX1 and YBX3 are
present in HeLamitochondria (Fig. 5B). Similar to themito-
chondrial marker proteins TOM20 and ATP5A1, both
YBX1 and YBX3 were detectable in a crude mitochondrial
preparation purified by sedimentation through a sucrose
cushion (lane 1). However, proteinase K treatment of the
mitochondrial fraction fully removed YBX1 and YBX3 as
well as TOM20 that is located at the outer surface of the
mitochondria (lane 2) (Chen et al. 2012). In contrast,
ATP5A1 that resides in the mitochon-
drial inner membrane remained re-
sistant to proteolysis in the absence
of detergent. These results confirmed
that YBX1 and YBX3 are missing from
the mitochondria and further support
the conclusion that they interact with
mt tRNAs in the cytosol.
Next, we prepared a cytoplasmic
soluble extract devoid ofmitochondri-
al contaminations (Baghirova et al.
2015). To this end, HeLa cells were in-
cubated with a digitonin-based ex-
traction buffer that permeabilizes the
plasma membrane but leaves intact
the mitochondrial membranes (Fig.
5C). The resulting cytosolic extract
contained both cytoplasmic (Gln and
Thr) and mitochondrial (Phe and Lys)
tRNAs as well as YBX1 and YBX3
(lane 2), but in contrast to the total
sonic extract (lane 1), it lacked the
ATP5A1, TOM20, andCyt cmitochon-
drial marker proteins as well as the
COXIII mitochondrial mRNA. IP of
YBX1 and YBX3 from the digitonin ex-
tract recovered both mt tRNAPhe and
mt tRNALys, but failed to pull down
cyt tRNAs Gln and Thr (lanes 4,5), fur-
ther demonstrating that YBX1 and
YBX3 interact with mt tRNAs in the cy-
tosol outside of mitochondria. Com-
paring the relative mt tRNA levels in
our digitonin and total sonic extracts
indicated that ∼0.1% to 1% of cellular
mt RNAs reside in the cytosol (Supplemental Fig. S5).
Autophagic turnover of mitochondria supports
mt tRNA release into the cytosol
The observations that mt tRNAs interact with cytosolic
RNA-binding proteins, such as YBX1 and YBX3 (this study),
PTB, and Argonaut 2 (Maniataki and Mourelatos 2005;
Marnef et al. 2016) raise the question how mt tRNAs can
accumulate in the cytoplasm, because the mitochondrial
membrane is impermeable for macromolecules. Dys-
functional or superfluous mitochondria are eliminated by
selective lysosomal degradation, called mitochondrial
autophagy or mitophagy (Kim et al. 2007; Ashrafi and
Schwarz 2013; Rodger et al. 2018). To test whether mt
tRNAs could be released into the cytosol during autopha-
gic turnover of mitochondria, HeLa cells were treated
with valinomycin that induces mitochondrial autophagy
or with chloroquine that inhibits lysosomal activity (Geor-
gakopoulos et al. 2017). Total cellular and cytosolic
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FIGURE 5. YBX1 and YBX3 associate with mt tRNAs in the cytosol. (A) Cell fractionation. YBX1
and YBX3 were immunoprecipitated from HeLa cytoplasmic and nuclear soluble extracts (low-
er panels). Co-IP of mt tRNAs was monitored by northern blot analyses (upper panels). (Lanes
no Ab) Control IPs without antibody. Distribution of the U2 nuclear and the Y5 cytoplasmic
RNAs was also tested. (B) YBX1 and YBX3 are not detectable in HeLa mitochondria. Crude mi-
tochondrial fraction (lane 1) was digested with proteinase K in the absence (lane 2) and pres-
ence (lane 3) of Triton X-100 before western blot analyses of YBX1, YBX3, and the
mitochondrial marker proteins TOM20 and ATP5A1. (C ) HeLa YBX1- and YBX3-mt tRNA com-
plexes are present in a cytosolic extract devoid of mitochondrial contamination. A HeLa cyto-
solic extract was prepared by gentle digitonin extraction (lane 2) and its protein (YBX1, YBX3,
ATP5A1, Cyt c, and TOM20), mRNA (COXIII), and tRNA (mt tRNAPhe, mt tRNALys, cyt tRNAGly
and cyt tRNAThr) contents were compared to those of a diluted (10 times) total cell sonic extract
(lane 1). Co-IP of mt tRNAs Phe and Lys with YBX3 and YBX1 from the digitonin extract was
confirmed.
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extracts were prepared from nontreated, valinomycin-
treated, and chloroquine-treated cells by sonication and
gentle digitonin extraction, respectively. In each extract,
the concentrations of mt tRNAs Lys and Phe andmitochon-
drial marker proteins ATP5A1 and TOM20weremonitored
(Fig. 6A). Confirming efficient induction of mitophagy,
ATP5A1, TOM20, mt tRNALys, and mt tRNAPhe levels
were reduced in the valinomycin-treated total cell extract
as compared to the nontreated and chloroquine-treated
control extracts. In contrast, induction of mitophagy had
no influence on the global cellular accumulation of
GAPDH and cyt tRNAGln(TTC). Consistent with expectations,
ATP5A1, TOM20, and theCOXIII mRNAweremissing from
the digitonin cytosolic extract (see Supplemental Fig. S6).
Accumulation of both mt tRNALys and mt tRNAPhe was in-
creased in the cytosol of valinomycin-treated cells, con-
trary to their reduced global accumulation in these cells.
Again, the cyt tRNAGln(TTC) levels remained unaltered in
the cytosolic fractions of control and valinomycin-treated
cells. Quantitation of eight independent experiments per-
formed by slot blot analyses confirmed that the cytosolic
concentrations of mt tRNAs Lys and Phe increased about
2.5-fold to threefold in HeLa cells undergoing valinomy-
cin-induced mitophagy (Fig. 6B). Because the cytoplasm
of valinomycin-treated cells lacked mitochondrial marker
proteins and the COXIII mitochondrial mRNA, we exclud-
ed the possibility that elevated cytosolic mt tRNA accumu-
lation was due to increased mitochondrial membrane
fragility (Supplemental Fig. S6).
To further demonstrate that mitophagy promotes cyto-
solic accumulationofmt tRNAs,wecompared the cytoplas-
mic distributions of mt tRNAGln in nontreated (NT) and
valinomycin-treated HeLa cells by using fluorescence in
situ hybridization microscopy (Fig. 6C). In control cells,
the mt tRNAGln hybridization signals followed the overall
patterns of mitochondrial structures highlighted by immu-
nostainingwith an anti-ATP5A1antibody. The tRNAsignals
not overlapping with anti-ATP5A1 staining might indicate
the cytoplasmic fraction of mt tRNAGln. As expected, vali-
nomycin treatment largely reduced the global accumula-
tion of ATP5A1, and the remaining ATP5A1 showed less
colocalization with mt tRNAGln. The nonoverlapping frac-
tion of mt tRNAGln had an uneven speckled distribution
mainly around the remaining cytoplasmic mitochondria.
Identical results were obtained upon visualization of the in-
tracellular localizationofmt tRNAPhe in valinomycin-treated
cells (Supplemental Fig. S7), supporting the idea that auto-
phagic degradation of mitochondria promotes the release
of mt tRNAs into the surrounding cytoplasm.
Transcription inhibition increases YBX1 and YBX3
association with mt tRNAs
We tested whether YBX1 and YBX3 formmetabolically sta-
ble complexes with mt tRNAs or their interactions depend
A B
C
FIGURE 6. Induction of autophagy increases soluble cytosolic mt
tRNA levels. (A) Accumulation of mt tRNAs in the cytosol of HeLa cells
undergoing autophagy. Cytosolic and total cellular extracts were pre-
pared from HeLa cells nontreated (NT) or treated with chloroquine
and valinomycin bymild digitonin extraction or sonication, respective-
ly. The levels of mt tRNAs Lys and Phe and the mitochondrial proteins
ATP5A1 and TOM20 were measured by northern and western blot-
ting. (B) Accumulation of mt tRNAs in the cytosolic extracts of HeLa
cells either nontreated (NT) or treatedwith chloroquine or valinomycin
wasmeasured by slot blot analysis followed by PhosphorImager quan-
titation in eight independent experiments. Relative mt tRNA accumu-
lations normalized to the levels of cyt tRNAGln(TTC) are depicted by
boxplots generated with the ggplot2 package (v2.2.1) in RStudio
(v0.99.903 with R v3.3.1). The means and standard deviations (sd)
are indicated. The obtained values for chloroquine- and valinomy-
cin-treated cells were compared to the values obtained for NT control
cells in a statistical analysis using Student’s t-test. (C ) Cytoplasmic
distribution of mt tRNAGln after induction ofmitophagy. HeLa cells, ei-
ther treated or nontreated (NT) with valinomycin, were hybridizedwith
a fluorescently labeled oligodeoxynucleotide specific for mt tRNAGln.
Mitochondria were stained with antibodies against ATP5A1. Bars,
10 µm. Lower panels show enhanced magnifications of the boxed cy-
toplasmic areas (13.4×13.4 µm). Nuclei were visualized with DAPI
staining.
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on the actual transcriptional or physiological conditions of
the cell. HeLa cells were treated with α-amanitin (a-ama),
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), and
actinomycin D (ActD) to arrest nuclear RNA synthesis
(Bensaude 2011). After extract preparation, YBX1 was im-
munoprecipitated and its association with mt tRNAs Lys,
Phe, Leu(UUR), and Val was measured by slot blot analysis
followed by PhosphorImager quantitation. For each inter-
action, we performed 12 independent transcription inhibi-
tion and IP experiments. After incubation with a-ama for 3
h or with DRB and ActD for 1 h, YBX1 showed increased as-
sociations with mt tRNAs Lys, Phe, and Leu(UUR) (Fig. 7A).
Interestingly, mt tRNAVal association with YBX1 only mod-
erately increased in response to transcription inhibition,
further supporting the assumption that mt tRNAVal has a
unique cytoplasmic function (see Fig. 3C).
Because the transcriptional inhibitory effect of DRB is re-
versible (Bensaude 2011), HeLa cells were grown for 1 h in
the presence and an additional hour in the absence of DRB
(Fig. 7B). One hour after DRB removal (2 h), the increased
YBX1 and mt tRNA association levels (1 h) returned to the
original or in the case of mt tRNAVal, even below the orig-
inal level (0 h). We have previously observed that interac-
tion of PTB with mt tRNAThr increases in apoptotic HeLa
cells (Marnef et al. 2016). However, upon induction of ap-
optosis by STS administration, association of HeLa YBX1
and YBX3 with mt tRNAs was significantly reduced (Fig.
7C). Nevertheless, these results collectively demonstrate
that YBX1 and YBX3 associate with mt tRNAs in dynamic
and regulated manners.
Interaction of mt tRNAs with various mRNP proteins
Our findings that human mt tRNAs specifically bind to hu-
man mRNP proteins YBX1, YBX3, and PTB prompted us
to test whether other randomly selected mRNP proteins
can also interact with mt tRNAs. Transiently expressed
Flag-tagged SR proteins SRSF1, SRSF2, and SRSF3 and en-
dogenous HeLa hnRNP A1 and H proteins were immuno-
precipitated (Fig. 8A), and the associated RNAs were
A B C
FIGURE 7. Dynamic association of YBX1 withmt tRNAs. (A) Transcription inhibition increases YBX1 association with mt tRNAs. HumanHeLa cells
were nontreated (NT) or treated with α-amanitin (a-ama), 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), or actinomycin D (ActD). After
extract preparation, YBX1 was immunoprecipitated and coprecipitation of mt tRNAs Leu(UUR), Lys, Phe, and Val was measured by slot blot anal-
yses and PhosphorImager quantification. For each transcription inhibitor, 12 independent inhibition, IP, and slot blot experiments were per-
formed and the obtained relative hybridization intensity values were normalized to the means of values obtained for nontreated control cells.
The means and standard deviations (sd) for each condition are indicated. The obtained values of treated cells were compared to the values ob-
tained for NT control cells in a statistical analysis using Student’s t-test. For conditions statistically different from the corresponding control con-
dition, the significance levels are indicated. (B) DRB treatment of HeLa cells increases YBX1 association with mt tRNAs in a reversible manner.
YBX1 association with mt tRNAs Leu(UUR), Lys, Phe, and Val was measured in nontreated HeLa cells (0 h), in cells grown for 1 h in the presence
(1 h) and for another hour in the absence of DRB (2 h). Other details are identical to panel A. (C ) YBX1 and YBX3 association with mt tRNAs is
decreased in apoptotic cells. YBX3 and YBX1 were immunoprecipitated from extracts prepared from HeLa cells nontreated (NT) or treated
with staurosporine (STS) for 4 h. Co-IP of mt tRNAs was measured as described in panel A.
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analyzed by gel electrophoresis (Fig. 8B). IP of each protein
recovered a set of small RNAs falling into the size range of
mt tRNAs. Northern blot analysis of the SR protein–associ-
ated RNAs with the complete set of mt tRNA oligonucleo-
tide probes or hnRNP A1– and hnRNP H–associated RNAs
with probes complementary to the
five longest mt tRNAs demonstrated
that the testedmRNPproteins interact
with mt tRNAs (Fig. 8C,D). The hnRNP
A1 and H bind predominantly to mt
tRNAs Asn, Gln, and Phe. The SR pro-
teins interact with many mt tRNAs,
although SRSF1 associates most ef-
ficiently with mt tRNAs Val, Gln, and
Asn, SRSF2 binds mainly to mt
tRNAGln, and SRSF3 interacts prefer-
entially with mt tRNAs Phe, Val, Arg,
and Ser (Agy). The identity of mt
tRNAs shown in Figure8Bwas inferred
from their electrophoretic mobility
and northern hybridization intensity.
In transcriptionally arrestedHeLacells,
both SR and hnRNP proteins showed
increased associations with their mt
tRNA partners, corroborating the con-
clusion that association of mRNP pro-
teins with mt tRNAs is dynamic and it
reversibly correlates with the tran-
scriptional activity of the cell (Fig. 8E).
DISCUSSION
Human cytoplasmic mRNAs dyna-
mically associate with hundreds of
RNA-binding proteins that control
mRNA translation, stability, and local-
ization (Singh et al. 2015). In this
study, we have demonstrated that be-
sides binding to cytoplasmic mRNAs,
human mRNP proteins YBX1, YBX3,
SRSF1, SRSF2, SRSF3, and hnRNP
A1 and H also interact with mt
tRNAs. Whereas YBX1, YBX3, and
the three SR proteins bind to many
mt tRNAs, hnRNP A1 and H interact
predominantly with three mt tRNAs,
Asn, Gln, and Phe (Figs. 1C, 8), and
another earlier characterized mRNP
protein, PTB, binds to mt tRNAThr
with great specificity (Marnef et al.
2016). The mt tRNA-binding abilities
of PTB, YBX1, and YBX3 were recog-
nized accidentally. Because all other
mRNP proteins selected for mt tRNA
co-IP assays, SRSF1, SRSF2, SRSF3,
and hnRNP A1 and H, have been found to interact with
mt tRNAs (Fig. 8), we believe that many additional mRNP
proteins possess mt tRNA binding capacity.
In vitro reconstitution and in vivo cross-linking experi-
ments demonstrated that similar to PTB (Marnef et al.
A
B
D E
C
FIGURE 8. Interaction of mRNP proteins with HeLamt tRNAs. (A) Western blot analyses. HeLa
endogenous hnRNP A1 and H and transiently expressed Flag-tagged SRSF1, SRSF2, and
SRSF3 proteins were immunoprecipitated and analyzed by western blotting. Control IPs
from nontransfected cells (NT) or without antibody (no AB) are shown. (B) Small RNAs coimmu-
noprecipitated with Flag-tagged SRSF1, SRSF2, and SRSF3 and hnRNP A1 and H proteins
were 3′ end-labeled and analyzed on 6% sequencing gels. (C ) SR proteins interact with mt
tRNAs. Co-IP of mt tRNAs with Flag-tagged SRSF1, SRSF2, and SRSF3 proteins was monitored
by northern blot analyses. (Ext) Input extract (50× dilution). (D) Interaction of HeLa hnRNP A1
andHwithmt RNAs. (E) Dynamic association of mRNP proteins with mt tRNAs. HeLa cells non-
transfected (hnRNP A1 and H) or transfected with the pFL-SRSF1, pFL-SRSF2, or pFL-SRSF3
expression plasmids were divided into two fractions which were treated or nontreated with
ActD. After extract preparation, the transiently expressed Flag-tagged SRSF1, SRSF2, and
SRSF3 and endogenous hnRNP A1 and H proteins were immunoprecipitated and the copuri-
fied mt tRNAs were analyzed on a sequencing gel.
Human mRNP proteins bind to mitochondrial tRNAs
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2016), YBX1 and YBX3 directly interact with mt tRNAs
(Figs. 3A,B, 4). All known mt tRNA-associated mRNP pro-
teins possess RNA-binding capacity, and they carry one
(SRSF2 and SRSF3), two (SRSF1, hnRNP A1 and H), or
four (PTB) RNA recognition motifs (RRMs). The CSD of
YBX1 and YBX3 also has RNA-binding affinity and encom-
passes the RNP1 and RNP2 consensus sequences present
in RRMs (Sachs et al. 2012). Earlier, mutational analyses
demonstrated that the RRM1 and RRM2 motifs of PTB rec-
ognize theD and T stem–loops of mt tRNAThr in an interde-
pendent manner, and these two protein–RNA contacts
provide high specificity for the PTB-mt tRNAThr interaction
(Marnef et al. 2016). It is unclear whether both RRMs pres-
ent in SRSF1, hnRNP A1, and H, participate in mt tRNA
binding, but apparently, the single RRMs carried by
SRSF2 and SRSF3 are able to support efficient mt tRNA
binding. Mutations introduced into the RNA-binding sur-
face of the CSD of YBX1 disrupt mt tRNA binding, demon-
strating that the CSD coordinates mt tRNA binding (Fig.
4B,C). Similar to the RRM1 and RRM2 motifs of PTB, the
CSD of YBX1 recognizes the T or D stem–loop regions of
mt tRNAs (Fig. 4A). Compared to cyt tRNAs, mt tRNAs pos-
sess distinctive structural features, they fold into nonca-
nonical cloverleaf structures that lack D loop/T loop
interactions, or mt tRNASer(AGY) lacks even the entire D
stem–loop (Watanabe 2010; Suzuki et al. 2011). Thus, ac-
cessibility of the D and T stem–loops seems to be the ma-
jor structural determinant of specific association of mt
tRNAs with mRNP proteins.
Cell fractionation experiments demonstrated that YBX1,
YBX3, and PTB interact with mt tRNAs in the cytosol out-
side of mitochondria (Fig. 5; Marnef et al. 2016). Most
probably, SRSF1, SRSF2, SRSF3, and hnRNP A1 and H
also interact with mt tRNAs in the cytoplasm, because
none of these proteins has been detected in themitochon-
dria (Mootha et al. 2003; Pagliarini et al. 2008; Gaston et al.
2009). We have demonstrated that lysosomal degrada-
tion of superfluous or dysfunctional mitochondria, called
mitophagy, represents at least one mechanism that can
support mt tRNA release into the cytosol (Fig. 6). It remains
unclear whether mt tRNAs are liberated from dysfunctional
or damaged mitochondria before being targeted to auto-
phagic degradation, or they can simply escape lysosomal
RNA hydrolyses. About 30% of YBX1-associated mt
tRNAs Phe and Lys lack an intact 3′-terminal CCA motif,
suggesting that they undergo partial exonucleolytic deg-
radation maybe during mitophagy or later in the cytosol.
In this context, it is noteworthy that mt tRNAs transfected
into HeLa cells show unexpectedly highmetabolic stability
thatmight be a consequence of their association with cyto-
solic mRNA proteins.
At the moment, the functional significance of cytosolic
mt tRNA accumulation and association with mRNP pro-
teins remains elusive. The observation that interaction of
mt tRNAs and mRNP proteins is highly dynamic and it is
governed by the actual transcriptional and physiological
conditions of the cell point to a potential cytosolic regula-
tory role of mt tRNAs. It raises the fascinating possibility
that mt tRNAs released into the cytosol in response to var-
ious physiological changes in the mitochondria may sup-
port a regulatory cross-talk between mitochondria and
nuclear gene expression. Recently, cyt tRNA-derived frag-
ments (tRFs) generated by the hypoxic stress–inducible
endoribonuclease angiogenin have been proposed to
control human mRNA translation and decay through bind-
ing to YBX1 (Fu et al. 2009; Thompson and Parker 2009;
Yamasaki et al. 2009; Ivanov et al. 2011). In response to
hypoxic stress, 5′ tRFs were proposed to destabilize
some prooncogenic mRNAs by displacing their 3′ untrans-
lated regions from YBX1 (Goodarzi et al. 2015). In princi-
ple, cytoplasmic mt tRNAs may also control mRNA
stability, translation, and/or localization through competi-
tive displacement of various mRNP proteins. It is also con-
ceivable that mt tRNAs accumulating in the cytoplasm
function simply as molecular decoys andmay providemet-
abolic and/or conformational stability for mRNA-binding
proteins dissociated from cytoplasmic mRNPs. Finally,
YBX1 and other mRNP proteins may also bind to cytoplas-
mic mt tRNAs to target them to the exosomes and/or ex-
tracellular vesicles (Shurtleff et al. 2017).
Our results also support the possibility that mt tRNAs
may have several different functions in the cytoplasm.
During apoptosis, Cyt c and PTB show increased interac-
tions with mt tRNAs in general and with mt tRNAThr, re-
spectively (Mei et al. 2010; Marnef et al. 2016). In
contrast, YBX1 and YBX3 association with mt tRNAs is re-
duced in apoptotic cells (Fig. 7C). Although mt tRNAs
Lys, Phe, and Leu(UUR) form only small, heterodimeric
complexes with YBX1 and YBX3, the YBX1- and YBX3-mt
tRNAVal complexes are incorporated into larger (35S–
60S) higher order structure(s) of unknown nature (Fig.
3D). Understanding of the cytoplasmic function(s) of mt
tRNAs is a technically highly challenging task, because
we cannot manipulate mt tRNA accumulation in the cyto-
plasm. Apparently, induction of mitophagy, although it
augments mt tRNA concentrations in the cytoplasm, has
complex physiological impacts on the cell. On the other
hand, RNA interference or transfection of in vitro tran-
scribed mt tRNAs are not efficient approaches to signifi-
cantly modulate the interaction of HeLa mt tRNAs with
YBX1 and other mRNP proteins (Marnef et al. 2016; B
Jady, A Ketele, T Kiss, unpubl.). Dissection of the precise
role of mt tRNA–mRNP protein complexes remains an im-
portant task for the future.
In summary, we have demonstrated that human mt
tRNAs dynamically interact with cytoplasmic mRNP pro-
teins. Although the functional role of cytoplasmic mt
tRNA association with mRNP proteins remains unknown,
our results provide strong support to the emerging view
that besides mediating mitochondrial protein synthesis,
Jády et al.
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human mt tRNAs released into the cytoplasmmay possess
additional important cellular functions.
MATERIAL AND METHODS
General procedures and cell cultures
Unless stated otherwise, standard laboratory protocols were used
for manipulating RNA, DNA, oligonucleotides, and proteins.
Oligodeoxynucleotides were purchased from Eurofins MWG.
Mouse L929 and human HeLa, MCF7, MRC5V1, U2OS, VA13,
and primary fibroblast cells were grown in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 10% fetal calf serum
(Invitrogen). RNA transcription was inhibited by incubation of
HeLa cells with 20 µg/mL of α-amanitin (a-ama) (Sigma-Aldrich)
for 3 h, with 100 µM of 5,6-dichloro-1-β-D-ribofuranosylbenzimi-
dazole (DRB) (Sigma-Aldrich) and 1 µg/mL Actinomycin D (ActD)
(Sigma-Aldrich) for 1 h. Apoptosis was induced by incubation of
HeLa cells with 1 µM of STS (Sigma-Aldrich) for 4 h. To induce
or to inhibit mitophagy, HeLa cells were incubated for 16 h with
1 µM of valinomycin or with 10 µM of chloroquine, respectively
(Georgakopoulos et al. 2017). Transfection of HeLa cells with ex-
pression plasmids and in vitro transcribed RNAs was performed
by using Lipofectamine 2000 (Invitrogen) as recommended by
the manufacturer.
Construction of expression plasmids
To obtain pFL-YBX1 and pXpress-YBX1, the full-length YBX1
cDNA was PCR-amplified and inserted into the HindIII and
BamHI sites of the p3XFLAG-CMV (Sigma-Aldrich) or into the
BamHI and XhoI sites of the pcDNA3.1/HisC (Invitrogen), respec-
tively. To generate pHA-YBX1 and pHA-YBX3, YBX1 and YBX3
cDNAs were amplified using 5′-terminal primers encoding two
copies of the influenza hemagglutinin (HA) tag peptide and the
amplified DNAs were inserted into the HindIII and BamHI sites
of pcDNA3 (Invitrogen). The same approach was used for con-
struction of pFL-YBX3 except that the 5′-terminal PCR primer en-
coded two copies of the Flag tag. To obtain pXpress-YBX1CSDm,
appropriate point mutations were introduced into the pXpress-
YBX1 expression plasmid by using PCR-mediated mutagenesis.
To generate pFL-SRSF1, pFL-SRSF2, and pFL-SRSF3, full-length
cDNAs of human SRSF1, SRSF2, and SRSF3 were inserted into
the HindIII/EcoRI or EcoRI/BamHI (SRSF3) sites of p3XFLAG-
CMV (Sigma-Aldrich).
Immunoprecipitation, antibodies, and protein
analyses
Preparation of cell extracts and IP of proteins were performed
essentially as described before (Marnef et al. 2014, 2016). About
9×106 cells were suspended in 0.5 mL of ice-cold NET-150
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Nonidet P-40)
buffer and sonicated five times for 30 sec with 30-sec intervals
with a Bioruptor Plus sonicator (Diagenode) at high setting. Cell
debris were removed by centrifugation at 16,000g for 10 min,
and in some experiments, the extracts were further clarified
from large RNPs by centrifugation at 100,000g for 20 min.
Cytosolic extract was prepared by mild digitonin extraction of
HeLa cells. About 9×106 PBS-washed cells were resuspended
in 500 µL of digitonin extraction buffer (50 mM HEPES, pH 7.4,
150 mMNaCl, 1 M hexylene glycol, 25 µg/mL digitonin) and gent-
ly agitated by end-over-end rotation for 15 min at 4°C. Cells were
removed by centrifugation at 2000g for 10 min at 4°C and the su-
pernatant was further clarified by centrifugation at 13,000g for 10
min at 4°C. For IP, 20 µL of packed protein A Agarose beads
(Sigma-Aldrich) coupled with 5 µL of monoclonal anti-YBX1
(ab76149, Abcam), anti-mYBX1 (ab12148, Abcam), anti-hnRNP
A1 (sc32301, Santa Cruz), anti-hnRNP H (ab10374, Abcam),
anti-Flag (F3165, Sigma-Aldrich) and anti-HA (clone HA-7,
Sigma-Aldrich) and polyclonal anti-YBX3 antibodies (produced
by Agro-Bio) were incubated with 450 µL cell extract for 1 h at
4°C. Beads were washed four times with ice-cold NET-150. In
vivo RNA–protein cross-linking was performed as described be-
fore (Niranjanakumari et al. 2002), except that the RNA IP (RIPA)
and wash buffers contained 0.2% sodium dodecyl sulfate (SDS).
For western blot analyses, the following antibodies were used
in the indicated dilutions: monoclonal anti-YBX1 (1:4,000)
(ab12148, Abcam), polyclonal anti-YBX3 (1:2,000) (Agro-Bio),
monoclonal anti-Flag-HRP (1:100,000) (A8592, Sigma-Aldrich),
monoclonal anti-HA-HRP (1:5,000) (ABIN 1573874, GenScript),
monoclonal anti-Xpress (1:5,000) (Invitrogen), monoclonal anti-
hnRNPA1 (1:2,000) (sc32301, SantaCruz),monoclonal anti-hnRNP
H (1:3,000) (ab10374, Abcam), anti-ATP5A1 (1:1000) (459240,
Invitrogen), anti-TOM20 (1:1000) (612278, BDTransduction Labo-
ratories), anti-Cyt C (556433, BD Pharmingen) (1:500).
RNA analyses
From cell extracts and IP pellets, RNAs were isolated by phenol–
chloroform extraction. For northern blot analyses, RNAswere frac-
tionated on 6% sequencing gels, electroblotted onto a Hybond-
N nylon membrane (GE Healthcare) and probed with 5′ end-la-
beled sequence-specific oligodeoxynucleotides (sequences are
available upon request). For slot blot analyses, RNAs recovered
from the pellets of YBX1 and YBX3 IP reactions were immobilized
on a nylonmembrane using a slot blot apparatus and probedwith
radiolabeled oligonucleotides. The hybridization reactions were
analyzed by PhosphorImager quantitation. In vitro 3′ end labeling
of RNAs with [5′-32P]pCp and T4 RNA ligase (Thermo Scientific)
and chemical sequencing of terminally labeled, gel-purified mt
tRNAs have been described (Kiss et al. 1985; Kiss and Solymosy
1990). RNA 3′ end race analysis has been reported (Kiss and
Filipowicz 1993).
In vitro transcription of wild-type and mutant
mt tRNAs
Template DNAs for in vitro synthesis of internally labeled wild-
type and mutant mt tRNAs and cyt tRNAGln(TTG) were generated
by PCR amplification with appropriately designed oligodeoxynu-
cleotide primers incorporating the bacteriophage T7 promoter. In
vitro RNA synthesis was performed in the presence of 0.2 µg of
template DNA, 10 units of T7 RNA polymerase (Promega), and
50 µCi of [α-32P]-CTP (specific activity 30–40 Ci/mmol). For syn-
thesis of cold RNAs, [α-32P]-CTP was omitted. Before utilization,
each RNA product was purified on a 6% sequencing gel.
Human mRNP proteins bind to mitochondrial tRNAs
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Recombinant YBX1 and YBX3 purification
and electrophoretic mobility shift assay
To generate pSCodon-YBX1 and pSCodon-YBX3 bacterial ex-
pression vectors, YBX1 and YBX3 cDNAs were amplified by
RT-PCR using 5′ primers encoding the Strep-Tactin tag and the re-
sulting DNA fragments were inserted into the BamH1 and HindIII
sites of pSCodon1 (Delphi Genetics). A similar approachwas used
to produce pSCodon-YBX1CSDm, except that the pXpress-
YBX1CSDm expression plasmid was used as a template for PCR
amplification. E. coli Rosetta strains transformed with the
pSCodon-YBX1, pSCodon-YBX3, or pSCodon-YBX1CSDm ex-
pression plasmids were grown overnight at 18°C in 5 L of 2× YT
medium complemented with 100 µg/mL ampicillin, 100 µg/mL
chloramphenicol, and 0.3 mM IPTG. Cells were harvested and re-
suspended in 200 mL of 50 mM NaH2PO4, 300 mM NaCl, 1 mM
imidazole (pH 8.0) solution, and they were disrupted by freezing
and sonication four times for 30 sec by a Branson sonifier at set-
ting 5. After centrifugation at 9000g for 25 min, the clarified ex-
tracts were incubated with 1 mL of Ni-NTA-agarose beads
(Qiagen) for 1 h at 4°C. Beads were washed four times with 50
mM NaH2PO4, 300 mM NaCl, and 10 mM imidazole (pH 8.0)
buffer and the bound proteins were eluted with 50 mM
NaH2PO4, 300 mM NaCl, and 150 mM imidazole (pH 8.0).
Proteins were loaded on a Strep-Tactin Superflow Plus cartridge
(Qiagen) and were washed twice with 50 mM NaH2PO4, pH 8.0,
containing first 300 mM then 150 mMNaCl. Proteins were eluted
with 50 mM NaH2PO4, 150 mM NaCl (pH 8.0) solution comple-
mented with 2.5 mM desthiobiotin. The purified proteins were
frozen and kept at −80°C in 20% glycerol. Electrophoretic mobil-
ity shift assay has been described before (Marnef et al. 2016).
Cell fractionation
HeLa cells (∼2×107) were suspended in 2 mL of ice-cold hypo-
tonic buffer A (10 mM HEPES-KOH, pH 7.9, 1.5 mM MgCl2,
10 mM KCl, 0.5 mM dithiothreitol) and incubated on ice for
10 min. Cells were broken in a Dounce homogenizer using pestle
B by 15 strokes and the homogenate was centrifuged at 600g for
5 min. The obtained pellet and supernatant were considered as
crude nuclear and cytoplasmic fractions, respectively. Nuclei
were washed once in nuclei wash buffer (10 mM Tris-HCl, pH
7.5, 3.3 mM MgCl2, 250 mM sucrose), resuspended in 0.5 mL of
NET-150, and sonicated five times for 30 sec with 30-sec intervals
by a Bioruptor Plus sonicator (Diagenode) at high setting. The re-
sulting homogenate was clarified by centrifugation at 16,000g for
10 min to generate a soluble nuclear extract. The crude cytoplas-
mic fraction was further clarified by three subsequent centrifuga-
tion steps at 1000g, 10,000g, and 16,000g for 5 min in each case.
Finally, the obtained soluble cytoplasmic extract was supple-
mented with 40 µL of 5 M NaCl and 0.5 µL of Nonidet P-40.
For preparation of mitochondria, HeLa cells (∼2×107) were
washed in TD buffer (25 mM Tris-HCl, pH 7.5, 133 mM NaCl,
5 mM KCl, 0.7 mM Na2HPO4,) and resuspended in 2 mL of RSB
buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 1.5 mM CaCl2).
Cells were incubated on ice for 10 min and homogenized with a
Dounce homogenizer using pestle B by 15 strokes. The extract
was completed with 1.3 mL, 2.5× MS buffer (12.5 mM Tris-HCl,
pH 7.5, 525 mM mannitol, 175 mM sucrose, 12.5 mM EDTA).
Nuclei were removed by three sequential centrifugations at
1250g for 5 min at 4°C and mitochondria were collected by cen-
trifugation at 20,000g, for 15 min at 4°C. Themitochondrial pellet
was resuspended in 1 mL of 50 mM Tris-HCl, pH 7.5, 10 mM
EDTA and 20% sucrose, and layered onto a sucrose cushion com-
posed of two layers of 7 mL 1.5 M and 1.0 M sucrose solutions in
10 mM Tris-HCl, 5 mM EDTA. After centrifugation at 65,000g for
20 min, mitochondria were recovered from the interphase of the
two sucrose cushions with a Pasteur pipette, supplemented with
0.5 mL 1× MS buffer, and collected by centrifugation at
20,000g for 10 min at 4°C.
Sucrose gradient analysis
HeLa cells (∼2×107) were suspended in 500 µL of NET-150 buffer
and sonicated five times for 30 sec with 30-sec intervals in a
Bioruptor Plus sonicator (Diagenode) at high setting. The cell ho-
mogenates were clarified by centrifugation at 16,000g, for 10 min
at 4°C. Extracts corresponding to 2 mg of cellular proteins were
layered on top of a 10%–50% sucrose gradient containing 10
mM Tris-HCl, pH 7.5, 150 mMNaCl, and 1.5 mMMgCl2 and cen-
trifuged in a SW41Ti swing-out rotor at 188,000g for 150min. The
gradients were fractionated into 14 fractions by an ISCO UA-6
gradient collector.
Fluorescent in situ hybridization microscopy
Oligodeoxynucleotides A∗GTGTATTGCTTTGAGGAGGTAAGC
TACAT∗ (Gln), A∗ATGGGGTGATGTGAGCCCGTCTAAACATA∗
(Phe1) and A∗AGTGTATTGCTTTGAGGAGGTAAGCTACATA∗
(Phe2) carrying C6-aminoallyl-modified nucleotides (marked by
asterisks) were labeled with FluoroLink Cy3 monofunctional reac-
tive dye (GE Healthcare) and were used as probes for in situ hy-
bridization to mitochondrial tRNAs (http://www.einstein.yu.edu/
labs/robert-singer/protocols/). Hybridization was carried out
in 2× SSC containing 20% formamide. Mitochondria were detect-
ed with anti-ATP5A1 (1:100 dilution) (459240, Invitrogen).
Slides were mounted in mounting media (90% glycerol, 1× PBS,
0.1 µg/mL DAPI, 1 mg/mL p-phenylenediamin). Raw images
were acquired using NIS-Elements AR software on a Nikon TI-E/
B inverse microscope with CFI Plan APO VC 100× 1.4 objective
and a Hamamatsu OrcaR2 CCD camera (binning 1 or 2). Final im-
ages were prepared with Adobe Photoshop.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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